BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9005339)

  • 1. [Familial combined hyperlipidemia].
    Bredie SJ; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2528. PubMed ID: 9005339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial combined hyperlipidemia].
    Kastelein JJ; ten Cate JW
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):747-8. PubMed ID: 9213793
    [No Abstract]   [Full Text] [Related]  

  • 3. Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjects.
    Gehrisch S; Steinke M; Kostka H; Hoche I; Julius U; Jaross W
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():64-5. PubMed ID: 8767466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial combined hyperlipidemia].
    Takagi A; Ikeda Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):76-9. PubMed ID: 9645012
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity.
    Bredie SJ; Demacker PN; Stalenhoef AF
    Eur J Clin Invest; 1997 Oct; 27(10):802-11. PubMed ID: 9373757
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-density lipoprotein subclass phenotypes and familial combined hyperlipidemia.
    Austin MA
    Diabetes Metab Rev; 1991 Sep; 7(3):173-7. PubMed ID: 1817002
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan.
    Badzioch MD; Igo RP; Gagnon F; Brunzell JD; Krauss RM; Motulsky AG; Wijsman EM; Jarvik GP
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1942-50. PubMed ID: 15331429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
    Vakkilainen J; Pajukanta P; Cantor RM; Nuotio IO; Lahdenperä S; Ylitalo K; Pihlajamäki J; Kovanen PT; Laakso M; Viikari JS; Peltonen L; Taskinen MR
    Eur J Hum Genet; 2002 Sep; 10(9):547-52. PubMed ID: 12173032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of "familial combined hyperlipidemia".
    Brunzell JD; Motulsky AG
    Prog Clin Biol Res; 1984; 147():403-5. PubMed ID: 6739492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital defects of post-heparin lipoprotein lipase. Diagnosis of familial combined lipoproteinemia].
    Titov VN
    Klin Lab Diagn; 2003 Jun; (6):10-7. PubMed ID: 12910637
    [No Abstract]   [Full Text] [Related]  

  • 11. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
    Lee JC; Lusis AJ; Pajukanta P
    Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial combined hyperlipidemia].
    de Bruin TW; Dallinga-Thie GM; Erkelens DW
    Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
    [No Abstract]   [Full Text] [Related]  

  • 14. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
    de Graaf J; Stalenhoef AF
    Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
    Reymer PW; Groenemeyer BE; Gagné E; Miao L; Appelman EE; Seidel JC; Kromhout D; Bijvoet SM; van de Oever K; Bruin T
    Hum Mol Genet; 1995 Sep; 4(9):1543-9. PubMed ID: 8541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene.
    Near SE; Wang J; Hegele RA
    J Hum Genet; 2001; 46(8):490-3. PubMed ID: 11501949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
    [No Abstract]   [Full Text] [Related]  

  • 19. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between familial combined hyperlipidemia and insulin resistance.
    Jackuliaková D; Vaverková H; Karásek D
    Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.